A Chart Review on the Feasibility and Safety of the Vincristine Irinotecan Pazopanib (VIPaz) Association in Children and Adolescents With Resistant or Relapsed Sarcomas

Background: Pediatric patients with relapsed or refractory sarcomas have poor outcome and need novel therapies that provide disease control while maintaining an acceptable quality of life. The safety of vincristine, irinotecan, and pazopanib (VIPaz) association has not yet been published in this pop...

Descripción completa

Detalles Bibliográficos
Autores principales: Russo, Ida, Di Paolo, Virginia, Crocoli, Alessandro, Mastronuzzi, Angela, Serra, Annalisa, Di Paolo, Pier Luigi, Di Giannatale, Angela, Miele, Evelina, Milano, Giuseppe Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425124/
https://www.ncbi.nlm.nih.gov/pubmed/32850366
http://dx.doi.org/10.3389/fonc.2020.01228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425124/
https://www.ncbi.nlm.nih.gov/pubmed/32850366
http://dx.doi.org/10.3389/fonc.2020.01228

Ejemplares similares